These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 19575730
1. Observational cross-sectional study comparing Breslow thickness of melanoma arising from naevi and melanoma de novo. Garcia-Cruz A, Flórez A, de la Torre-Fraga C, Cruces Prado M. Br J Dermatol; 2009 Sep; 161(3):700-2. PubMed ID: 19575730 [No Abstract] [Full Text] [Related]
5. Observational study on the mitotic rate and other prognostic factors in cutaneous primary melanoma arising from naevi and from melanoma de novo. Betti R, Santambrogio R, Cerri A, Vergani R, Moneghini L, Menni S. J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1738-41. PubMed ID: 24673663 [Abstract] [Full Text] [Related]
11. Moles and melanoma: the pathological basis of clinical management. Levene A. Proc R Soc Med; 1972 Feb; 65(2):137-40. PubMed ID: 5085015 [No Abstract] [Full Text] [Related]
12. Melanoma in organ transplant recipients: the old enemy finds a new battleground. Dinh QQ, Chong AH. Australas J Dermatol; 2007 Nov; 48(4):199-207. PubMed ID: 17956476 [Abstract] [Full Text] [Related]
13. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi. Friedman RJ, Rigel DS, Kopf AW, Lieblich L, Lew R, Harris MN, Roses DF, Gumport SL, Ragaz A, Waldo E, Levine J, Levenstein M, Koenig R, Bart RS, Trau H. Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885 [Abstract] [Full Text] [Related]
14. Histopathologic study of recurrent Clark level II melanomas. Glass LF, Guffey JM, Schroer KR, Reintgen D. Semin Surg Oncol; 1993 Jun; 9(3):202-7. PubMed ID: 8516604 [Abstract] [Full Text] [Related]